Betamethasone Dipropionate

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

48 API Suppliers, 16 USDMF, 8 CEP/COS, 6 JDMF, 7 EU WC, 2 KDMF, 10 NDC API, 32 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

8 Drugs in Development

8 Drugs in Development

FINISHED DOSAGE FORMULATIONS

143 FDF Dossiers, 79 FDA Orange Book, 7 Europe, 3 Canada, 24 Australia, 9 South Africa, 21 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

OINTMENT, AUGMENTED;TOPICAL - EQ 0.05% BASE, CREAM;TOPICAL - EQ 0.05% BASE;1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CREAM;TOPICAL - EQ 0.05% BASE, OINTMENT;TOPICAL - EQ 0.05% BASE, CREAM, AUGMENTED;TOPICAL - EQ 0.05% BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, LOTION, AUGMENTED;TOPICAL - EQ 0.05% BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, OINTMENT;TOPICAL - 0.064%;0.005%, SUSPENSION;TOPICAL - 0.064%;0.005%

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc, 2 SPI Pharma, 3 DKSH, 1 Gangwal Healthcare, 7 Nanjing Well Pharmaceutical, 1 Actylis, 1 Alcedo Pharmachem, 11 BASF, 1 Clariant, 4 Corel Pharma Chem, 2 Finar, 1 Kerry, 4 Lubrizol Life Science Health, 11 Roquette, 1 Seppic, 2 Shandong Focus Biotechnology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 1 Valens Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

26 Topical, 13 Film Formers & Plasticizers, 9 Emulsifying Agents, 7 Solubilizers, 6 Lubricants & Glidants, 6 Thickeners and Stabilizers, 6 Parenteral, 5 Fillers, Diluents & Binders, 5 Coating Systems & Additives, 4 Taste Masking, 4 Controlled & Modified Release, 3 Direct Compression, 3 Surfactant & Foaming Agents, 2 Granulation, 2 Chewable & Orodispersible Aids, 1 Soft Gelatin, 1 Rheology Modifiers, 1 Co-Processed Excipients

DIGITAL CONTENT

1 DATA COMPILATION #PharmaFlow, 48 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

3 US Medicaid Prescriptions, 17 Finished Drug Prices, 9 Annual Reports

MARKET PLACE

21 APIs, 1 FDF Dossiers

PATENTS & EXCLUSIVITIES

20 US Patents

20 US Patents

REF. STANDARDS & IMPURITIES

3 EDQM, 1 USP, 5 Others

$ Xls

Filters

Xls

USFDA APPLICATION NUMBER - 21852 / DOSAGE - OINTMENT;TOPICAL - 0.064%;0.005%

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
BETAMETHASONE DIPROPIONATE(UNII: 826Y60901U) (BETAMETHASONE DIPROPIONATE - UNII:826Y60901U)	BETAMETHASONE DIPROPIONATE	0.643mg in 1
CALCIPOTRIENE(UNII: 143NQ3779B) (CALCIPOTRIENE - UNII:143NQ3779B)	CALCIPOTRIENE	50ug in 1

Inactive Ingredients

Ingredient Name	LEO Pharma Inc.	Perrigo New York Inc	Sandoz Inc.	Warner Chilcott (US), LLC
.ALPHA.-TOCOPHEROL, DL-(7QWA1RIO01)
ALPHA-TOCOPHEROL, DL-(7QWA1RIO01)
BUTYLATED HYDROXYTOLUENE(1P9D0Z171K)
DIAZOLIDINYL UREA(H5RIZ3MPW4)
MEDIUM-CHAIN TRIGLYCERIDES(C9H2L21V7U)
MINERAL OIL(T5L8T28FGP)
PETROLATUM(4T6H12BN9U)
POLYPROPYLENE GLYCOL 11 STEARYL ETHER(S4G2J0Y0LG)
PPG-11 STEARYL ETHER(S4G2J0Y0LG)

Drug Product Composition: Betamethasone Dipropionate